Women’s Cancers: Gynecologic Cancer

Magee specializes in preventing, detecting, and treating gynecologic cancers such as ovarian, cervical, and uterine cancers. Nearly 500 women with gynecologic cancers are treated each year at Magee’s nationally recognized Gynecologic Cancer Program.

Magee’s experts work together to develop the best strategies for diagnosing and treating the patient’s type of gynecologic cancer, including cancers of the:

Your support allows researchers at the Women’s Cancer Research Center at Magee-Womens Research Institute to study new screening and prevention tools, early detection, and effective alternative therapies for women who have incomplete or toxic responses to standard treatment. Magee-Womens Research Institute’s cancer biology team is also tackling the fundamental processes that lead to cancer, focusing on the role of the immune system in tumor formation–particularly in ovarian cancer–with an emphasis on anti-cancer vaccine development.

Basic studies also center on genetic and epigenomic pathways that contribute to cancer. A prime goal in the group’s translational research labs is to identify biomarkers for cancer risk, severity, prognosis, and response to therapy. The group also focuses on large-scale clinical trials, performed as a part of the national Gynecologic Oncology Group consortium, conducting trials involving ovarian, cervical, endometrial, and vulvar cancers.